Thirty-year changes in burden for refraction disorders in China, Japan, Korea and Singapore: a jointly prevention perspective analysis Authors: Xiuyu Mao, Wenchang Jia, Shunmei Ji, Lei Wu, Binghong Chen, Xiaopan Li Published: 2025 ABSTRACT AbstractBackgroundUncorrected refractive error is a primary cause of global vision impairment, creating substantial health and economic burdens. This study aimed to analyze historical trends in the burden of refractive disorders from 1990 to 2021 and to project future trends to 2050, focusing on global, socio-demographic, and key Asian regional levels.MethodsData on the prevalence and YLDs of refractive disorders were obtained from the Global Burden of Disease Study 2021. We analyzed age-standardized rates (ASR) globally, across five Socio-Demographic Index (SDI) quintiles, and for five Asian regions. Temporal trends were evaluated using Joinpoint regression to calculate the average annual percent change (AAPC). Future burden until 2050 was projected using a Bayesian Age-Period-Cohort (BAPC) model.ResultsFrom 1990 to 2021, the global age-standardized prevalence rate (ASPR) of refractive disorders decreased by 6.5%. The most significant declines occurred in low-SDI (11.8%) and low-middle-SDI (20.0%) regions. Among the selected Asian regions, Taiwan (10.1%) and China (6.4%) demonstrated the largest reductions. The burden was disproportionately high in older populations, with prevalence peaking in the 80–84 age group. Projections indicate a future shift in disease burden, with the ASPR in Japan and Taiwan forecasted to surpass that of China within the next decade.ConclusionWhile significant progress has been made in reducing the burden of refractive disorders, particularly in lower-SDI regions, the burden is increasingly concentrating in the aging populations of higher-SDI countries. These findings underscore the urgent need for targeted public health strategies and enhanced eye care services to address the challenges posed by these demographic shifts.Keywords: Refractive disorders, Visual impairment, Global burden of disease, Trend analysis, Asia Introduction Global context of visual impairment Visual impairment represents a significant global health concern, with uncorrected refractive error (URE) —including myopia, hyperopia, astigmatism, and presbyopia—standing as the leading cause of moderate to severe vision impairment worldwide [1, 2]. URE diminishes quality of life and imposes a considerable economic burden on society [2]. In response, the World Health Organization (WHO) has endorsed a global target to increase effective refractive error coverage (eREC) by 40% points by 2030 [1, 3]. eREC is a crucial indicator that measures the proportion of people in need of refractive services who have not only received care but also achieved a good-quality visual outcome as a result [4]. Despite this, a significant gap in coverage persists. In 2022, global eREC for distance in adults aged 50 and older was 42.9%, while near vision eREC was only 20.5%, highlighting a substantial unmet need [1]. Disparities in vision health are pronounced across demographic groups. Women are disproportionated affected, accounting for an estimated 55% of the global population living with blindness [5], particularly in low- and middle-income regions. Coverage also tends to decline with increasing age, with older adults facing greater barriers to care [1, 5]. This demographic shift is particularly acute in several East Asian regions, such as China, Japan, the Republic of Korea, and Singapore, which are classified as “aging societies.” With the proportion of individuals over 65 projected to rise significantly by 2050 (rise from 10% in 2020 to 16% in 2050 globally. In 2021, 13.1% of people in China (Mainland), 29.8% of people in Japan, 16.7% of people in the Republic of Korea, and 14.1% of people in Singapore were older than 65), understanding the long-term trajectory of refractive disorders in these areas is crucial for public health planning. Therefore, this study aims to analyze the temporal trends in the prevalence and burden of refractive disorders from 1990 to 2021 and to project these trends to 2050. We provide a comprehensive assessment at the global, socio-demographic, and regional levels, with a specific focus on five high-income, aging societies in Asia. Methods Data sources and definitions All data for this study were obtained from the Institute for Health Metrics and Evaluation (IHME) website (https://www.healthdata.org/data-tools-practices/data-sources), using estimates from the Global Burden of Disease Study 2021. The research strategy is provided in Fig. 1. Our study was conducted in accordance with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) [6] (Table S1). We extracted annual estimates of prevalence and years lived with disability (YLDs) for refractive disorders from 1990 to 2021. Analyses were stratified globally, by the five Socio-Demographic Index (SDI) quintiles [7] (low, low-middle, middle, high-middle, high), and for five Asian regions: China (mainland), Taiwan (province of China), Japan, Republic of Korea, and Singapore. Age-standardized rates (ASR) were calculated using the GBD 2021 global reference population to enable valid comparisons across different populations and time periods. SDI is a composite indicator of development status calculated by the GBD project. It is based on a scale of 0 to 1 and is derived from the geometric mean of three components: income per capita, average educational attainment in the population over age 15, and total fertility rate under 25. The study strategy in the study: a diagram Statistical analyses To quantify temporal trends, we calculated the average annual percent change (AAPC) for age-standardized prevalence rates (ASPR) and age-standardized YLDs (ASYLDs) from 1990 to 2021. This analysis was performed using the Joinpoint Regression Program (Version 4.9.0.0), with the calendar year as the independent variable. Analyses were further stratified by sex and 18 distinct age groups. A p-value of < 0.05 was considered statistically significant. For all estimated metrics, 95% uncertainty intervals (UIs) were reported. Forecasting and model validation Future projections of ASPR and ASYLDs from 2022 to 2050 were generated using a Bayesian Age-Period-Cohort (BAPC) model. This model was selected for its ability to disentangle the effects of age, time, and birth cohort on disease trends. To ensure predictive accuracy, the model was validated through a back-testing exercise where data from 1990 to 2015 were used to forecast rates for 2016–2021; these projections were then compared against observed GBD 2021 estimates, confirming the model’s robustness. Projections were calculated using population forecasts from the UN World Population Prospects 2022 (https://www.un.org/development/desa/pd/content/World-Population-Prospects-2022). Results Trends in age-standardised prevalence rate (ASPR) from 1990 to 2021 As shown in Fig. 2, the global ASPR decreased by 6.5% from 2,053.56 per 100,000 (95% UI: 1,835.31-2.31.31.31.31,275.8) in 1990 (Fig. 2A) to 1,919.66 (95% UI: 1,715.24-2.24.24.24.24,135.28) in 2021 (Fig. 2D). This decline was most pronounced in lower-SDI regions, with the low-middle SDI quintile showing a 20.0% reduction and the low-SDI quintile an 11.8% reduction. In contrast, trends in the selected Asian regions varied. China and Taiwan experienced significant declines of 6.4% and 10.1%, respectively, while Japan (0.7%), the Republic of Korea (2.6%), and Singapore (2.8%) showed smaller decreases over the 32-year period. A consistent downward trend in ASPR was observed annually, except for a slight increase in high-SDI regions after 2012 (Fig. 3). The age-standardised rate of prevalence in the five regions in 1990 and from 2019 to 2021 Forest plot: the trends in the AAPC of age-standardised prevalence rate (ASPR) Trends in age-standardised YLDs (ASYLD) from 1990 to 2021 Table 1 presents the global burden of disability from refractive disorders declined, with the largest reductions in ASYLDs occurring in low-middle (−25.6%) and low (−16.4%) SDI regions. High-middle and high SDI regions showed minimal reductions of 4.6% and 0.1%, respectively. Among Asian regions, Taiwan showed the highest decrease in ASYLDs (15.2%), followed by China (11.3%), Singapore (4.5%), Republic of Korea (4.0%,), and Japan (1.51%). Japan showed a slight increase in its ASYLD trend, with an AAPC of 0.06% (95% UI: 0.05 to 0.07), whereas Taiwan demonstrated a decreasing trend with an AAPC of −0.34% (95% UI: −0.36 to −0.32) (Fig. 4). Table 1The ASR of YLDs in 1990. 2019, 2020 and 2021 globally, in different SDI regions and in five Asian countries or regionsCountriesASR of YLDs in 1990ASR of YLDs in 2019ASR of YLDs in 2020ASR of YLDs in 2021Rate95%UIRate95%UIRate95%UIRate95%UI Global 88.05(62.19,125.12)80.31(55.85,115.91)80.15(55.72,115.45)79.11(54.94,114.14) SDI Regions Low SDI107.51(77.28,149.96)90.74(63.47,127.28)90.19(63.34,126.56)89.83(62.99,126.44) Low-middle SDI155.74(110.64,218.12)117.35(81.42,167.47)116.83(80.79,166.64)115.83(80.19,165.8) Middle SDI99.52(71.22,139.6)89.54(62.8,128.27)89.38(62.58,128.24)87.81(61.5,126.03) High-middle SDI72.61(50.92,104.27)71.70(49.72,103.87)71.10(49.41,102.4)69.30(47.97,100.35) High SDI48.76(32.97,71.38)48.85(32.92,71.49)48.96(33.07,71.59)48.70(32.87,71.38) East Asia China (Mainland)74.31(53.94,102.01)70.66(50.09,98.82)69.88(49.57,97.83)65.89(46.69,92.19) Taiwan (Province of China)42.44(28.54,63.15)36.34(23.72,54.45)35.87(23.25,53.36)35.98(23.44,54.17) Japan43.63(29.53,63.75)42.87(29.08,62.82)42.99(29.17,62.88)42.97(29.12,62.88) Republic of Korea53.42(36.26,77.55)50.69(34.04,74.37)50.88(34.31,74.31)50.73(34.16,74.59) High-income Asia pacific Singapore66.81(44.41,98.26)63.85(42.63,93.38)63.80(42.41,94.11)63.83(42.24,95.04) The ASR of YLDs in 1990. 2019, 2020 and 2021 globally, in different SDI regions and in five Asian countries or regions Forest plot: the trends in the AAPC of age-standardised YLDs rate (ASYLDs) Age difference in ASPR and ASYLDs from 1990 to 2021 The burden of refractive disorders was strongly associated with age (Fig. 5B). Globally, the prevalence rate peaked in the 80–84 years age group (5,242.66 per 100,000), while the YLD rate increased steadily with age, rising from approximately 16 per 100,000 in the youngest groups to over 300 per 100,000 in the 80–84 years group (Fig. 5A). Among the five Asian regions, China had the highest YLD rate for individuals aged 45 and older. The YLDs rate and prevalence rate in 2021 in different age groups Projections to 2050 Projections to 2050 indicate a significant shift in the regional burden of refractive disorders (Fig. 6). The ASPR for men in Japan (Fig. 6C) is projected to surpass that of men in China (Fig. 6A) by 2023, with a similar crossover for women expected in 2032. Consequently, the ASYLDs for Japanese men (Fig. 6F) are forecasted to exceed those for Chinese men (Fig. 6D) by 2027, and for women by 2038. Similarly, Taiwan’s ASPR (Fig. 6B) is projected to overtake China’s (Fig. 6A) for both men (2027) and women (2032). These forecasts suggest a concentrating burden in the more rapidly aging populations of Japan and Taiwan. The age-standardised rate of prevalence (ASPR) and YLDs (ASYLDs) from 1990 to 2021, and projection from 2021 to 2050, divided by gender Discussion This study’s findings align with the global recognition of refractive errors as a leading cause of vision impairment, while also highlighting key regional and socioeconomic variations. Our results show a general decrease in the burden of refractive disorders from 1990 to 2021, with the most substantial declines observed in low and low-middle SDI regions, suggesting that global and national eye health initiatives may be having a positive impact. However, the concurrent finding of a slower decline and even a slight increase in burden in high SDI regions from 2012 to 2021, coupled with the high prevalence in older age groups, underscores the persistent challenge of uncorrected presbyopia and changing lifestyle factors. Socioenvironmental factors and dietary influences The five regions investigated share comparable socioenvironmental characteristics, including low birthrates, highly pressured educational systems [8], a high degree of technology integration into daily life, as well as substantial consumption of rice, noodles, and seafood. These factors may contribute to the observed patterns of refractive disorders. For instance, the KNHANES Study [9] found that a diet rich in carbohydrates, polyunsaturated and n-6 fatty acids (which are abundant in seafoods), vitamins, and minerals was associated with a reduced prevalence of high myopia-related problems in adults, potentially contributing to the observed patterns of refractive disorders. Urbanization and lifestyle factors The rise of urbanization, increasing workload and excessive Internet usage contributed to a higher prevalence of refractive disorders, predominantly among the younger generation worldwide [10, 11]. A sedentary lifestyle and prolonged near-work have been identified as significant risk factors for the development of myopia and other refractive errors [12–14]. This trend extends beyond the younger population, with a remarkable increase in both prevalence and YLDs in low SDI and low-middle SDI regions beyond the age of 40.15 Presbyopia prevalence and impact Even in high and middle-high SDI regions, uncorrected presbyopia remains a significant issue. Despite available treatments such as eyedrops, spectacles, soft contact lens, laser surgery or interocular lens [16], 45% of the two-billion presbyopic population worldwide still lack sufficient correction. The impact of uncorrected refractive errors extends beyond vision, with studies revealing associations between URE in older people and memory decline [17] and increased risk of falls [18]. Clinical implications for adults with high refractive error It is also critical to consider the long-term consequences for adults with high myopia, a group susceptible to irreversible vision impairment. Individuals whose best-corrected visual acuity (BCVA) falls to ≤ 6/18 (20/60) in the better eye are classified as having low vision. This condition is often caused by myopic macular degeneration, retinal detachment, or glaucoma, all of which are more prevalent in those with high myopia [19, 20]. This population faces significant challenges, including difficulties with daily activities, reduced employment opportunities, and a diminished quality of life. The burden on healthcare systems is substantial, as these individuals require comprehensive low-vision rehabilitation services, including orientation and mobility training and assistive technologies, which are often under-resourced [21–23]. Our findings of high YLD rates in older populations indirectly reflect this burden, highlighting the need for health policies that focus not only on prevention but also on rehabilitation for those with irreversible impairment. Racial and age-related differences The Singapore Epidemiology of Eye Diseases Study provides insight into racial and age-related differences in refractive disorders. The study found that Chinese individuals and those aged 60 years or older were less likely to experience presbyopia progression compared to those aged 40–49 and other races like Malays and Indians [15]. This highlights the importance of considering demographic factors in the management of refractive disorders. Management strategies and interventions across Asian countries The discussion of management strategies is vital for translating research into policy. The five Asian regions have implemented various strategies to address the growing burden of refractive disorders, offering valuable models for other nations. In 2018, China announced a comprehensive national children’s myopia management plan [24, 25]. This coordinated approach involves multiple government bureaus and includes strategies such as reducing homework burden, increasing time spent outdoors, and discouraging risky behaviors like overuse of electronic devices. This top-down, multi-sectoral strategy is notable for its scale and integration, aiming to create a supportive environment for children’s eye health. Additionally, China has been working to address the dramatic spatial medical resource imbalance within the country. The eastern coastal region shows the highest medical resource abundance, with a decreasing trend from east to west, correlating strongly with regional GDP [26]. Efforts are being made to bridge provincial inequality and achieve universal health coverage (UHC) by addressing shortages in the general practitioner workforce and mitigating catastrophic payments [27]. Likewise, both Taiwan and Singapore have implemented school-based eye health programs that promote outdoor play, limit screen time, and provide regular vision screening and referral services [28, 29]. Singapore’s National Myopia Prevention Program, for instance, is a well-established initiative that combines public education campaigns with school-based interventions and has been credited with helping to stabilize myopia rates [30, 31]. Japan and the Republic of Korea, known for their advanced healthcare systems and high eye care accessibility, have focused on integrating regular vision checks into national health screening programs for both children and adults, ensuring early detection and management [32, 33]. The success of these programs provides a key take-home message: effective URE management requires a combination of public health campaigns, school-based interventions, and accessible clinical services. The effectiveness and cost-effectiveness of interventions targeting URE in the elderly population have been evaluated using randomized controlled trials and economic evaluations [34–37]. One study in Hong Kong [36] found that correcting the worse eye has a lower cost-effectiveness ratio, suggesting a potential strategy for resource allocation. However, it’s crucial to consider other factors beyond cost-effectiveness, such as individual needs, quality of life improvements, and long-term health effects. Technological innovations and future directions Artificial intelligence-based screening has shown promise in community health fairs [38] and could potentially improve eye health literacy worldwide. Early detection and timely management can help reduce preventable visual impairments [39]. A study conducted in China [40] showed that digital health education channels like messaging apps and digital reminders can improve compliance and maximize the effects of other interventions like outdoor time and spectacle wear, making the comprehensive digital strategy highly cost-effective compared to traditional approaches. Future projections and crossover points The projected crossovers in ASPR and ASYLD predictions of refractive diseases between Chinese males and females and those in Japan and Taiwan until the late 2020 s and early 2030 s can be attributed to several factors. Japan and Taiwan’s more advanced population aging, sophisticated healthcare systems with better eye care accessibility, and longer history of digital technology adoption contribute to higher prevalence rates. In contrast, China’s demographic transition is at an earlier stage, with a rapidly improving but still developing healthcare system and increasing digital lifestyle adoption. Gender differences may stem from varying life expectancies, healthcare-seeking behaviors, and technology usage patterns. The predicted crossover point could indicate when China’s eye care infrastructure and digital lifestyle converge with Japan and Taiwan’s, potentially shifting ASPR and ASYLD rates. Strengths and limitations This study’s strengths include its comprehensive analysis of long-term trends and future projections of refractive disorders across different regions and socioeconomic levels, with a specific focus on five Asian regions. The use of age-standardized rates allows for meaningful comparisons across regions and time periods, while the projections provide valuable insights for healthcare planning and resource allocation. However, there are several limitations to consider. First the study relies on data from the Global Burden of Disease Study 2021, which collates information from various sources. Data availability and quality may vary across countries, potentially leading to 25estimation or overestimation of refractive disorder prevalence and impact in certain areas. Second, the projections are based on current trends and assumptions, which may not account for potential changes in risk factors, healthcare access, or technological advancements that could influence the future burden of refractive disorders. Lastly, while the study focuses on five representative Asian countries or regions, the findings may not be generalizable to other countries or regions with different demographics, healthcare systems, and risk factor profiles. Conclusion In conclusion, this study confirms a significant, albeit varied, burden of refractive disorders across Asia and globally. Our analysis from 1990 to 2021 reveals a positive trend of decreasing prevalence and YLDs, especially in lower SDI regions, yet highlights a persistent and growing challenge in aging populations and high SDI regions. The projections to 2050 suggest that without targeted interventions, the burden in rapidly developing regions like China may converge with or even surpass that of historically high-prevalence countries like Japan. Addressing this requires a multifaceted approach, integrating the successful strategies observed in the studied regions—such as China’s national myopia plans and Singapore’s school-based programs—with a greater focus on the unaddressed needs of adults with presbyopia and the rehabilitation requirements of those with severe vision impairment from high myopia. Scaling up these proven interventions, adapting them to different socioeconomic contexts, and leveraging technological innovations are critical steps to reduce the burden of refractive disorders and improve vision health for all. Acknowledgements We would like to thank the Department of Health Management Center, Zhongshan Hospital Affiliated to Fudan University for providing access to the Global Burden of Disease Study 2021 data. We also express our gratitude to Dr. Xiangwu Chen from the Department of Ophthalmology, Zhongshan Hospital Affiliated to Fudan University for his valuable insights and brilliant suggestions during the preparation of this manuscript. Authors’ contributions XM wrote the main manuscript text. WJ and LW analyzed the data, and BC created all the figures. SJ and XL conceptualized the study. XL supervised the entire manuscript preparation process. All authors reviewed the manuscript and approved the final version. Funding This present study was sponsored by the National Natural Science Foundation of China (82401297), Zhongshan Hospital Project (2024ZSQN11), Construction of Key Medical Disciplines in Xuhui District (SHXHZDXK202306), and Shanghai Municipal Health Commission (No. 202340237). Data availability The data that support the findings of this study are available from the Global Burden of Disease Study 2021. Restrictions may apply to the availability of these data, which were used under license for the current study. Data are available from the authors upon reasonable request. Declarations Ethics approval and consent to participate This study used publicly available data from the Global Burden of Disease Study 2021. As such, no specific ethics approval or participant consent was required. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Xiuyu Mao, Wenchang Jia and Shunmei Ji contributed equally to the manuscript, and were listed as co-authors. References Associated Data Data Availability Statement The data that support the findings of this study are available from the Global Burden of Disease Study 2021. Restrictions may apply to the availability of these data, which were used under license for the current study. Data are available from the authors upon reasonable request.